top of page
Search

Optogenetics in Neural Circuit Manipulation (light systems)

Introduction

Optogenetics, a groundbreaking technique that precisely controls neural activity with the use of light-sensitive proteins, poses a new potential for neuroscience research. Researchers now can turn neurons on or off using brief flashes of light by genetically targeting specific neuron types to express opsins, a group of light-sensitive proteins that play a role in various light-dependent processes in organisms. This method has transformed neuroscience by enabling causal experiments in real-time behavior manipulation.


History and Origin

Gero Miesenböck, an Austrian neuroscientist, first worked with fruit flies, where “writing” activity with light replaced passive observation. Later, in 2005, Deisseroth and Boyden adapted microbial opsins for mammalian neurons, enabling excitatory (ChR2) or inhibitory (eNpHR) control through blue or yellow light. These single-component optogenetic tools allow cell-type precise manipulation of neural circuits across species. 


Light Delivery Systems

Over time, the method of delivering light into the brain changed from the usage of fiber-optic cables to wireless and more compact multi-wavelength systems. This progression fully integrates stimulation, electrical recording, and delivery into a biodegradable and multifunctional fiber. Two-photon and holographic optics have also enabled single-cell precision deep in scattering tissue.


Applications of Neural Circuit Research

Optogenetics has provided a new perspective for research on neural and brain function. A striking example is Deisseroth, who demonstrated blue light’s ability to drive a freely moving mouse in circles by stimulating neurons in the motor cortex. It has also been used to dissect circuits related to addiction, sleep, memory, emotions, schizophrenia, and other such chronic illnesses. Optogenetics is currently being explored for its applications in cardiology, gene therapy, and reproduction.


Current Challenges

Light penetration, the potential damage of brain tissue, immune response, and nonuniform opsin expression are significant challenges in current research. To address this, researchers are developing red-shifted opsins with deeper light penetration and engineered fibers that reduce invasiveness. Key advancements being tested include integrated photonic devices that multiplex beams for sub-millisecond precision, wireless modules, and biodegradable fibers. Constant improvements are being made to optogenetics to ensure accuracy and convenience.


Conclusion

By utilizing light to manipulate brain circuits, optogenetics has introduced intervention to neuroscience. It offers key temporal and spatial control, providing the potential for fundamental discoveries and therapies. As opsins progress and mature, revolutionary treatments like noninvasive deep‑brain stimulation and neural prosthetics can become promising for the future.

References:

Colapinto, John. “A Clear View of the Brain.” The New Yorker, 2017, www.newyorker.com/magazine/2015/05/18/lighting-the-brain.


‌Stamatakis, Alice M., and Garret D. Stuber. “Optogenetic Strategies to Dissect the Neural Circuits That Underlie Reward and Addiction.” Cold Spring Harbor Perspectives in Medicine, vol. 2, no. 11, 1 Nov. 2012, www.ncbi.nlm.nih.gov/pmc/articles/PMC3543095/, https://doi.org/10.1101/cshperspect.a011924.


‌Repina, Nicole A., et al. “At Light Speed: Advances in Optogenetic Systems for Regulating Cell Signaling and Behavior.” Annual Review of Chemical and Biomolecular Engineering, vol. 8, no. 1, 7 June 2017, pp. 13–39, www.ncbi.nlm.nih.gov/pmc/articles/PMC5747958/, https://doi.org/10.1146/annurev-chembioeng-060816-101254.


‌Bryce, Emma. “Shining a Light on How Neuroscientists Are Controlling Our Brains.” WIRED, 22 July 2016, www.wired.com/story/gero-miesenbock-neuroscience-light/. Accessed 22 June 2025.


‌Fenno, Lief, et al. “The Development and Application of Optogenetics.” Annual Review of Neuroscience, vol. 34, no. 1, 21 July 2011, pp. 389–412, https://doi.org/10.1146/annurev-neuro-061010-113817.

Quiz:


 
 
 

Comments


bottom of page